The role of nuclear imaging in the management of the first total artificial heart recipient.
On December 2, 1982, a permanent total artificial heart was implanted into the chest of a 61-year-old man with a progressive and irreversible cardiomyopathy. During the ensuing four-month hospitalization, a number of nuclear medicine procedures were obtained to assist in patient management. These procedures included gated cardiac radionuclide ventriculography, an I-123 iodoamphetamine scan for cerebral perfusion, and In-111 labeled leukocyte imaging. These radionuclide studies demonstrate the advantages of being able to monitor physiologic changes noninvasively and illustrate a potential role for nuclear cardiology in managing patients with a total artificial heart.
D000662:Amphetamines; D001921:Brain / Q000000981:diagnostic imaging*; D004761:Enterocolitis, Pseudomembranous / Q000000981:diagnostic imaging; D006321:Heart / Q000000981:diagnostic imaging*; D006354:Heart, Artificial; D006801:Humans; D007204:Indium; D007457:Iodine Radioisotopes; D020367:Iofetamine; D007962:Leukocytes; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D011183:Postoperative Complications / Q000000981:diagnostic imaging; D011868:Radioisotopes; D011877:Radionuclide Imaging; D013997:Time Factors
D000662:Amphetamines; D007457:Iodine Radioisotopes; D011868:Radioisotopes; D007204:Indium; D020367:Iofetamine